Affordable Drug Manufacturing Act of 2020 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying
Affordable Drug Manufacturing Act of 2020
USA116th CongressS-3162| Senate
| Updated: 1/8/2020
Affordable Drug Manufacturing Act of 2020 This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
Competition and antitrustCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationExecutive agency funding and structureFederal officialsGovernment employee pay, benefits, personnel managementHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth programs administration and fundingInflation and pricesLicensing and registrationsManufacturingPrescription drugsPublic contracts and procurementPublic participation and lobbying